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Histopathologic changes in the rabbit submandibular gland
after 5-fluorouracil chemotherapy
Oktay ÖZEL1, Abdullah AYÇİÇEK2, Fethullah KENAR2, Fatma AKTEPE3, Ramazan SARGIN2,
Mustafa Deniz YILMAZ2, Fevzi Sefa DEREKÖY2

Aim: To determine the early-stage effects of 5-fluorouracil (5-FU) on the histology of the submandibular gland.
Materials and methods: The study included 30 New Zealand rabbits. They were divided into 3 groups. No drugs were
administered to group 1 (control group), and 5-FU was administered for 5 days to group 2 and for 10 days to group 3.
Submandibular gland excision was then performed. Histopathological examination was performed with hematoxylin-eosin
staining, apoptosis was determined based on TUNEL staining, and cell proliferation was examined using the PCNA
antibody.
Results: While no granular change was seen in group 1, granular change was observed in the acinar cell cytoplasm in 5
rabbits in group 2 and in 5 rabbits in group 3 (P < 0.05). The rate of apoptosis in the acinar and ductal cells was higher in
group 3 than in groups 1 and 2, according to TUNEL staining (P < 0.05). While no cellular proliferation in the acinar cells
was observed with PCNA staining in any of the groups, there was a statistically significant difference in group 3 in ductal
cellular proliferation, as compared to groups 1 and 2 (P < 0.05).
Conclusion: Toxic effects of 5-FU were observed after 10 days. We suggest that a standard animal model can be developed
based on group 3 results. We also think that drug trials concerned with protecting the salivary gland from the effects of
chemotherapy can be conducted based on this model.
Key words: 5-Fluorouracil, mucositis, apoptosis, chemotherapy

5-Florourasil ile tedavi sonrası tavşan submandibuler bezinde gözlenen
histopatolojik değişiklikler
Amaç: Bu çalışmanın amacı 5-fluorouracil (5-FU)’in submandibuler gland histolojisi üzerindeki erken dönem etkilerini
değerlendirmektir.
Yöntem ve gereç: 30 adet Yeni Zelanda tipi tavşan üç gruba bölündü. 1. gruba (kontrol) ilaç verilmedi. 2. gruba 5 gün, 3.
gruba 10 gün 5-FU verildi. Tavşanlara submandibuler bez eksizyonu yapıldı. Hematoksilen-eozin boyama ile histopatolojik
muayene, TUNEL tekniğiyle apoptozis ve PCNA antikoru ile hücre proliferasyonu yapıldı.
Bulgular: 1. grupta hiçbir granüler değişiklik gözlenmezken, 2. ve 3. gruptaki 5 tavşanda asinüs hücre sitoplazmalarında
granüler değişiklik görüldü (P < 0,05). 3. grupta 1. ve 2. gruba göre TUNEL boyamayla asiner ve duktal hücrelerde daha fazla
apoptozis görüldü (P < 0,05). Tüm gruplarda PCNA boyamayla asiner hücrelerde hücresel proliferasyon gözlenmezken, 3.
grupta duktal hücre proliferasyonu istatistiki olarak anlamlı derecede farklıydı (P < 0,05).
Sonuç: Bu çalışmada 5-FU’nun tükrük bezi üzerine toksik etkilerinin 10. günden sonra başladığını saptadık. Bu çalışmada
olduğu gibi bir hayvan modeli geliştirilebileceğini ve bu modelle kemoterapi etkilerinden tükrük bezlerini koruyabilmek
için ilaç denemeleri yapılabileceğini önermekteyiz.
Anahtar sözcükler: 5-Fluorouracil, mukozit, apoptozis, kemoterapi
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Introduction
The mucositis status (stomatitis, esophagopharyngitis, and diarrhea) secondary to the stomatotoxic
effects of antineoplastic drugs increases the morbidity
and cost of treatment in cancer patients. This
complication also significantly affects the duration of
hospitalization and survival rates. Oropharyngeal pain,
eating and speech disorders, weight loss, oral infections,
bacteremia, and sepsis can be seen in patients with
mucositis. The risk of septicemia is 4-fold higher in
neutropenic patients with mucositis (1). Mortality is as
high as 40% in cases of severe ulceration (2). It was
suggested that 5-fluorouracil (5-FU) leads to mucositis
in 4%-74% of head and neck cancer cases, while the rate
of mucositis was reported to be 40% in patients treated
with chemotherapy (3).
In order to maintain oral hygiene, salivary glands
should have normal histology and physiology. While
the mucin glycoproteins in saliva decrease the
permeability of the oral mucosa, they also help
phonation, chewing, and swallowing by providing
lubrication. Antibacterial-affecting products in saliva,
such as lysozymes, lactoperoxidases, immunoglobulins,
lactoferrins, and histatins, provide for the continuity of
healthy oral mucosa. An effective agent or a gold
standard therapy for the prophylaxis of oral mucositis is
still not available (4).
5-FU is a fluorinated pyrimidine analogue used as
an antineoplastic drug (5). It was synthesized after the
observation that some tumor cells utilize uracil, a
pyrimidine base suitable for normal body cells. It
achieves its activity in the body by first transforming
into fluorouridylate (FUMP), and then transforming
into a type of deoxynucleotide—fluorodeoxyuridylate
(5-fluoro-2’-deoxyuridine 5’-monophosphate)—in
other words FdUMP (6). This active metabolite forms
the trio-complex, combining with thymidylate synthase
5-10
and N methylene tetrahydrofolate, a cofactor with
folate, and inhibits the thymidylate synthase enzyme.
When thymidylate production decreases in a cell,
thymine synthesis is disrupted and DNA synthesis
stops. Moreover, FUMP—formed from fluorouracil in
the body—plays a role in the structure of RNA and thus
disrupts RNA functions and protein synthesis (7,8);
however, the most important antitumoral effect of 5FU is the inhibition of thymidylate synthase (9).
5-FU sensitizes tissues to the effects of radiation;
therefore, it can be used simultaneously with
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radiotherapy in the primary treatment of head and
neck, esophageal, lung, and rectal tumors (10,11). The
primary side effects of 5-FU are anorexia,
gastrointestinal disturbances, such as nausea and
vomiting, and bone marrow depression. Doselimiting side effects are mucositis, such as stomatitis,
esophagopharyngitis, and diarrhea.
The aim of the present study was to determine the
early-stage effects of 5-FU on the histology of the
submandibular gland. Based on the obtained results,
a standard animal model could be developed in order
to monitor the histopathological changes following
chemotherapy. This standard animal model could be
used as a method to compare the efficacy of different
drugs in the prophylaxis of these types of
complications.
Materials and methods
Histopathological examination was performed
with hematoxylin-eosin (H&E) staining, apoptosis
was determined with TdT-mediated dUTP nick end
labeling (TUNEL), and cell proliferation was
determined using the proliferating cell nuclear
antigen (PCNA) antibody.
Tissue samples
The study included 30 healthy white New Zealand
rabbits weighing between 1800 and 2200 g. During
the study the rabbits were divided into 3 groups and
were supervised in a 15-m2 closed balcony system
illuminated by a night lamp. Mean temperature was
maintained at 22 ± 3 °C. Appropriate nutrition was
provided; the main food sources were green
vegetables, carrots, and tap water. The Afyon
Kocatepe University Animal Ethics Committee
approved the study protocol. Each animal that
–1
underwent surgery was anesthetized with 25 mg kg
®
IM ketamine hydrochloride (Ketalar , Eczacıbaşı
Parke-Davis, İstanbul, Turkey) and 5 mg kg–1 IM
xylazine HCl (Alfazyne®, Alfasan International B.V.
Woerden, Holland). Submandibular gland excision
was achieved surgically.
The 30 rabbits were divided into 3 groups, each
containing 10 rabbits. No drugs were administered to
group 1. Bilateral submandibular gland excision was
performed on these control group rabbits under
anesthesia (Table).
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Table. The study design.
Group

1 (control)
2
3

Number of
rabbits

Drug administration protocol
(dose, duration)

Date of submandibulary
gland excision

–

day 5

10
–1

10

–1

4 mg kg day , 5 days
–1

–1

4 mg kg day , (5 + 5 days)

10

Group 2 was administered 4 mg kg–1 5-FU IM (5FU®, Choongwae Pharma Corporation Seoul, Korea)
for 5 days. From day 6 to 11 no drugs were
administered to group 2. Bilateral submandibular
gland excision was performed in group 2 rabbits
under anesthesia on day 11.
–1

Group 3 was administered 4 mg kg 5-FU IM for
5 days. Between day 5 and 11 no drugs were
–1
administered to group 3. On day 11, 4 mg kg 5-FU
IM was again administered for another 5 days.
Bilateral submandibular gland excision was
performed on group 3 rabbits under anesthesia on day
16.
Two tissues were sampled from both right and left
submandibular gland material. Routine tissue
processing was performed after the sampled tissues
were fixed for 24 h in buffered formalin solution.
Then, 4-μm thick cross-sections were taken from
paraffin-embedded tissues and were examined under
a light microscope after H&E staining. During
microscopic
examination
irregularity
and
hypertrophy in cytoplasmic granules, inflammatory
cell infiltration, and fibrosis formation in acinar cells
were noted.
Immunohistochemical staining
In order to examine cellular proliferation in the
cross-sections placed on microslides with poly-Llysine, immunohistochemical staining was performed
according to the following procedure: the crosssections were made step by step:
1. Cross-sections were deparaffinized and
dehydrated.
2. They were boiled twice for 10 min in a 90-W
microwave oven in citrate buffer (pH 6).
3. They were washed with Tris buffered saline.

day 11
day 16

4. To stop endogenous peroxide activity, they
were incubated with 1% H2O2 for 5 min.
5. They were washed with Tris buffered saline.
6. They were incubated with PCNA antibody for
30 min (1:200 dilution, Neomarkers, USA) to
evaluate cell proliferation.
7. They were washed with Tris buffered saline.
8. They were incubated in biotinized horseradish
peroxidase (Labvision, USA) solution for 10
min.
9. They were washed with Tris buffered saline.
10. They were left in a 3-amino-9-ethylcarbazole
solution, as a chromogen, for 5-15 min while
the staining concentration was monitored.
11. They were processed with distilled water.
12. Mayer’s hematoxylin (10 min) was used for
contrast staining.
13. They were washed with distilled water.
14. They were assembled after drying.
The stained preparations were then examined
under a light microscope.
Immunohistochemical evaluation
In total, 500 acinar and ductal cells were counted,
and the nuclei that stained positively with PCNA
antibody were noted in every cross-section. The
number of positive cells in each group was calculated
and the mean values for each group were determined.
Mean group values were statistically compared.
TUNEL staining for apoptosis
The TUNEL (TdT-mediated dUTP nick end
labeling) technique was used to determine which cells
led to apoptosis in the tissues. Cross-sections 2-μm
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thick were placed on microslides with poly-L-lysine
for the staining procedure. The staining procedure
was performed according to the manufacturer’s
instructions (Roche-Applied-Science Cat no: 1 684
817); however, some modifications were made in
order to obtain optimum staining. The cross-sections
were treated as follows:

Statistical analysis
The chi-square test was used to compare the
results of H&E staining. The Kruskal-Wallis test was
used to compare the results of PCNA and TUNEL
staining.

1. They were deparaffinized and dehydrated.

Results

2. They were washed with PBS (phosphate
buffered saline).

Histopathological
examination
of
the
submandibular glands that were excised from the
rabbits in all 3 groups showed no evidence of fibrosis
or an increase in inflammatory cells. No granular
change in the cytoplasm of acinar cells was observed
in group 1 (control group) (Figures 1 and 2). Granular
changes were observed in 5 rabbits (50%) in group 2
and in 5 rabbits (50%) in group 3 (Figure 3). While
there was a statistically significant difference between
the control group and the other 2 groups (P < 0.05),
the difference between groups 2 and 3 was not
significant (P < 0.05).

3. They were incubated with 0.1% trypsin for 10
min at 37 °C.
4. They were boiled twice for 10 min in a 350-W
microwave oven.
5. They were washed with PBS.
6. They waited in 50 μL of the TUNEL mixture
solution at 37 °C for 60 min in a dark, moist
medium.
7. They were washed with PBS.
8. They were incubated in 50 μL of converterPOD (peroxidase) solution at 37 °C for 120
min in a moist medium.
9. They were washed with PBS.
10. They were incubated in 50-100 μL of
diaminobenzidine solution for 15-25 min.
11. They were washed with PBS.
12. Contrast staining was performed with
methylene green with 5 min of waiting at
room temperature.
13. They were washed with distilled water.
14. They were dried and assembled with glycerin.
Evaluation of apoptotic cells
Acinar and ductal cells that stained brown with
diaminobenzidine chromogen were counted in 10
different areas in every cross-section under a light
microscope at 400× magnification. The number of
apoptotic cells in 10 different microscopy areas was
calculated. The mean value of acinar and ductal
apoptotic cell groups was obtained for every salivary
gland, and these mean apoptotic cell group values
were compared.
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The rate of apoptosis in submandibular gland
acinar cells was higher in group 3 than in groups 1
and 2, based on histopathological examination with
TUNEL staining (Figure 4). While there was a
statistically significant difference between group 3 and
the other 2 groups in terms of the rate of apoptosis (P
< 0.05), a statistically significant difference was not
observed between groups 1 and 2 (P < 0.05).
The rate of apoptosis in submandibular gland
ductal cells was higher in group 3 than in groups 1
and 2, based on histopathological examination with
TUNEL staining (Figure 5). While there was a
statistically significant difference between group 3 and
the other 2 groups, in terms of the rate of apoptosis
(P < 0.05), a statistically significant difference was not
observed between groups 1 and 2 (P < 0.05).
Cellular proliferation in the acinar cells was not
observed in any of the groups with PCNA staining.
However, while there was a statistically significant
difference between group 3 and the other 2 groups, in
terms of cellular proliferation in ductal cells (P < 0.05)
(Figure 6), a significant difference was not observed
between groups 1 and 2 (P < 0.05). There was marked
hair loss, localized alopecia, malnutrition, and weight
loss in groups 2 and 3.
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Figure 1. Normal salivary gland; regular structured acini and
ducts. One-layered cubic epithelium is laid on the ducts
(H&E ×400).

Figure 2. Normal salivary gland; regular structured acini and
ducts. Acini have thin granulary cytoplasm (H&E
×400).

Figure 3. Chemotherapy effects in the acinus; the granules in the
acinus cell cytoplasms are irregular and large (H&E
×400).

Figure 4. Apoptotic cells that are stained brown in the acinus cells
(TUNEL ×400).

Discussion

cancers (12). Chemotherapeutic agents, such as 5-FU,
methotrexate, etoposide, and irinotecan, are
mucotoxic and increase the incidence of mucositis (4).
Not only do these stomatotoxic conditions negatively
affect the quality of life and nutrition of patients, they
delay implementation of treatment protocols and dose
reduction.

Oral mucositis is a serious complication that
increases morbidity and the cost of treatment in
cancer patients treated with radiotherapy and
chemotherapy. 5-FU is one of the most popular and
effective antineoplastic drugs used in the treatment of
head and neck cancers—including salivary gland
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Figure 5. Apoptotic ductal cells that are stained brown in the
ductus (TUNEL ×400).

Figure 6. Proliferative cells that are stained red in the nuclei of
ductal epithelial cells by PCNA antibodies
(Immunohistochemical staining ×400).

Reduced saliva secretion is one of the factors that
increase patient susceptibility to mucotoxic effects.
McCarthy et al. reported that 46% of patients had oral
mucositis during a 2-month follow-up of 63
gastrointestinal system cancer patients treated with 5FU, and that xerostomia increased their susceptibility
to mucositis (13). They also reported that the saliva
secretion rate is an important marker for oral
mucositis and highlighted the necessity of routine
follow-up of basal saliva secretion in patients that
receive stomatotoxic treatment. In contrast, Jensen et
al. suggested that such factors as the lack of standard
research methods, scarcity of research subjects, shortterm studies, and different treatment protocols
prevent a clear understanding of some of the effects
of chemotherapeutic agents on salivary gland
functions (14).

In the present study no inflammatory cell increase
or fibrosis was observed in the submandibular gland
cross-sections in any of the 3 groups upon light
microscopic examination. Granular changes were
observed in the cytoplasm of acinar cells in the
submandibular gland of the rabbits in groups 2 and 3;
the difference between the control group (group 1),
and groups 2 and 3 was statistically significant (P <
0.05). This condensation in the granules indicates
non-specific cytoplasmic degeneration and shows
reversible cellular damage (17). The secretory
granules, especially those seen in the serous cells,
include many proteolytic enzymes and heavy metals
(18). Normal rabbit submandibular gland histology
shows a mixed type, including serous tubules
proximally and seromucous acinar cells distally (19).

After 1 dose of methotrexate IP injection given to
rats, acinar and ductal cell vacuolization and swelling,
apoptosis in the acinar cells with pyknosis in the
nuclei, and a reduction in secretion granules were
reported as early pathological findings within the first
7 days, based electron microscopic examination (15).
The same authors also reported that the severity and
prevalence of pathological changes increased as
chemotherapeutic doses increased. McBride and
Siegel reported that the number of beta-adrenergic
receptors increased in the submandibular glands of
rats injected with methotrexate 15 mg kg–1 day–1 IP
for 3 days (16).

While apoptosis was not observed in groups 1 and
2 in the present study, it was observed in the acinar
and ductal cells in group 3. These results show that
the initial changes in normal salivary glands in rabbits
treated with 5-FU were observed in the cytoplasmic
granules. It was suggested that serous cells lead to
autolysis as a result of such granular damage, as well
as secretion of proteolytic enzymes in the granules
into the cytoplasm (20). Cellular infiltration towards
the subepithelial tissue, vascular dilatation, and
leukocyte margination were observed in oral mucosa
biopsies of rats treated with 5-FU and bleomycin as
early as 24 h after drug administration (4).
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We think that salivary gland damage does not play
a primary role in the development of mucositis, based
on the fact that granular changes were observed in
50% of the rabbits in groups 2 and 3 following 5-FU
administration for 5 and 10 days, respectively.
Apoptosis, as observed in the acinar and ductal cells
in group 3, shows that salivary gland damage
increased as the dose increased. Aota et al. reported
that 5-FU, which is often used in the treatment of
salivary gland cancer, induces apoptosis in salivary
gland cancer cells and that suppression of NF-κB
activity may be a mechanism involved in the
development of apoptosis (21). P53, c-jun, and
interferon-regulating factor 1 are other known
transcription factors associated with apoptosis (22).
Salivary gland malignancies are reported to be
resistant to both radiotherapy and chemotherapy (23).
A lifespan for salivary gland cells of between 60 and
120 days, low mitotic activity, and frequent G0 period
of the cell status are among the factors that account
for the resistance of tumors (24). In the present study
the development of apoptosis and cytoplasmic
granular changes in the acinar and ductal cells after
10 days of 5-FU administration shows that normal
salivary glands were affected by 5-FU.
In the present study PCNA antibody positivity,
which indicates proliferation in ductal cells, was
significantly higher in group 3 than in groups 1 and 2.
No proliferation was observed in the acinar cells in
any of the 3 groups. This finding suggests that
regeneration in the ductal cells after cellular damage
occurred earlier than in the acinar cells.

Conclusion
The present study determined that the first sign of
the effect of 5-FU on acinar cells in the
submandibular gland was changes in cytoplasmic
secretory granules, according to histopathological
examination with a light microscope. The damage
caused by these cytoplasmic secretory granules should
be considered among the mechanisms that lead to cell
apoptosis.
It is known that the signs of mucositis appear
within the first 24-48 h of the start of chemotherapy.
In contrast, it can be understood that the negative
effects of 5-FU on the salivary gland are not primary
factors in the development of mucositis, as a
statistically significant difference in the rate of
apoptosis was not observed between the control group
and group 3, based on cross-sections that were
examined after 11 days of 5-FU administration. It is
more plausible to consider that there is an association
between salivary gland functions and the
deterioration of late-stage mucositis.
We suggest that a standard animal model can be
developed based on group 3 results. We also think that
drug trials concerned with protecting the salivary
gland from the effects of chemotherapy can be
conducted according to this model.
The fact that proliferation occurred earlier in the
ductal cells is proof that regeneration or amelioration
began earlier than in the acinar cells. Nonetheless,
with the administration of a drug that protects
salivary gland functions, the appearance of such
regeneration in the acinar cells can be used as a
criterion.
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